Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 203
Ph III recruiting: 21
Growth YoY: +3.8%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05876130	Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer	recruiting	N/A	92	Samsung Medical CenterOTHER	1	Jun 12, 2024	clinicaltrials
NCT06417736	Prospective Study for Endometrial Carcinoma and Hyperplasia in Childbearing-age Women	recruiting	N/A	75	Women's Hospital School Of Medicine Zhejiang UniversityOTHER	1	May 16, 2024	clinicaltrials